Introduction
============

Podocytes, also known as visceral epithelial cells, are terminally differentiated cells of the kidney glomerulus, which have a key role in glomerular development and maintenance ([@b1-ijmm-41-06-3296]). The cytoskeletal dynamics and structural plasticity of podocytes, as well as the function of received and transmitted signals, are important for glomerular filtration and thus for renal function. Furthermore, podocyte injury participates in the occurrence and development of human and experimental glomerular diseases ([@b2-ijmm-41-06-3296]), among which, membranous nephropathy (MN) is recognized as an organ-specific autoimmune disease, which is well known to be associated with podocyte injury ([@b3-ijmm-41-06-3296]). The subepithelial immune complexes in MN in renal tissue immunofluorescence have been reported to contain circulating autoantibodies, intrinsic podocyte antigens ([@b4-ijmm-41-06-3296]) and complement components. Serum autoantibodies to phospholipase-A2-receptor have been suggested not only to be crucial in the advancement of MN, but also to act as a biomarker for diagnosis, disease activity and treatment efficiency ([@b5-ijmm-41-06-3296]).

Antibodies, also known as immunoglobulins (Igs), are expressed by B lymphocytes; however, accumulating evidence has indicated that Igs, including IgG, IgA and IgM, are produced in non-B lineage cells, such as epithelial cancer cells ([@b6-ijmm-41-06-3296]--[@b9-ijmm-41-06-3296]) and leukemic cells ([@b10-ijmm-41-06-3296]--[@b12-ijmm-41-06-3296]). Furthermore, several types of normal cells, including germ cells ([@b13-ijmm-41-06-3296],[@b14-ijmm-41-06-3296]), neurons ([@b15-ijmm-41-06-3296],[@b16-ijmm-41-06-3296]), endothelial cells ([@b17-ijmm-41-06-3296]) and skin epidermal cells ([@b18-ijmm-41-06-3296]), can also express Igs. Although non-B cell-derived Ig and traditional Ig have some similar characteristics, the former possesses unique characteristics, particularly with regards to structure and function. In contrast to the diversity of the Ig variable region, non-B cell-derived Ig tends to exhibit specific or restricted usage of certain sequences ([@b11-ijmm-41-06-3296],[@b19-ijmm-41-06-3296]). It has a unique glycosylation profile, through which the RP215 monoclonal antibody (mAb) can recognize non-B cell-derived Ig ([@b20-ijmm-41-06-3296],[@b21-ijmm-41-06-3296]). According to the results of previous studies, these Igs are essential for cell vitality and proliferation ([@b6-ijmm-41-06-3296],[@b22-ijmm-41-06-3296]--[@b24-ijmm-41-06-3296]), and are also associated with the migration, invasiveness and metastasis of cancer cells, thus suggesting that non-B Igs participate in tumorigenesis and development ([@b25-ijmm-41-06-3296],[@b26-ijmm-41-06-3296]). Furthermore, the regulatory mechanisms of gene expression have been explored in several studies ([@b27-ijmm-41-06-3296]--[@b29-ijmm-41-06-3296]).

The present study aimed to explore the expression of IgG in podocytes, and demonstrated that human podocytes may express and secrete IgG. In addition, not only was transcription of the constant region detected, V(D)J rearrangement of the variable region was demonstrated, and the expression levels of certain proteins were verified. Furthermore, the results suggested that podocyte-derived IgG may participate in the maintenance of cell morphology and growth.

Materials and methods
=====================

Podocyte culture
----------------

The conditionally immortalized human podocyte cell line was previously established, as reported in a previous study ([@b30-ijmm-41-06-3296]), and was donated by Professor Moin A. Saleem (Children\'s Renal Unit and Academic Renal Unit, University of Bristol, Bristol, UK). The study was approved by the ethics committee of Peking University Third Hospital (approval document issued on February 17th, 2016; under no. 053). The cells were cultured under growth-permissive conditions in RPMI-1640 medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 1% insulin-transferrin-selenium-A supplement (ITS; Gibco; Thermo Fisher Scientific, Inc.), 100 U/ml penicillin, 0.1 mg/ml streptomycin (Gibco; Thermo Fisher Scientific, Inc.) and 10% fetal bovine serum (FBS; Australian origin; Biological Industries USA, Cromwell, CT, USA) at 33°C. Podocytes were then incubated at 37°C without ITS for 10--14 days for differentiation; these cells were used for subsequent experiments. Protein and mRNA samples were collected from podocytes after 48 h stimulation with or without *Staphylococcus aureus* (SAC; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) at 37°C.

Immunofluorescence
------------------

The podocytes were cultured on cover-slips, which were fixed in 4% paraformaldehyde for 30 min at room temperature. Subsequently, 0.2% Triton X-100 was used to permeabilize the cells for 15 min at room temperature. The slides were washed in PBS and blocked with 5% bovine serum albumin (BSA; Invitrogen; Thermo Fisher Scientific, Inc.) at room temperature for 30 min, after which they were incubated with primary antibodies at 4°C overnight. The antibodies used were as follows: Rabbit anti-human IgG heavy chain (Igγ) (ab109489; 1:150), anti-human Igκ (ab134929; 1:250), anti-human Igλ (ab124719; 1:250) (all from Abcam, Cambridge, MA, USA), mouse anti-human Igγ4 (GI-0910; 1:200; Beijing Xiya Golden Bridge Biotechnology Co., Ltd., Beijing, China), rabbit anti-human F-actin (bs-1571R; 1:500; Beijing Bioss Biotechnology Co., Ltd., Beijing, China) and RP215 mAb (dilution, 1:200; donated by Professor Xiaoyan Qiu, Peking University, Beijing, China), which specifically identified a carbohydrate-associated epitope on non-B cell-derived Igγ. PBS was used as a negative control. After washing in PBS, the slides were incubated with fluorescein isothiocyanate-labeled goat anti-rabbit (ZF-0311; 1:200) or goat anti-mouse IgG antibodies (ZF-0312; 1:200) (both from Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd., Beijing, China) at room temperature for 1 h. Nuclei were stained with DAPI (C0060; 15 *µ*g/ml; Beijing SUOLAIBAO Biotechnology Co., Ltd., Beijing, China). Images were captured under a Leica DFC300 FX fluorescence microscope (Leica Microsystems GmbH, Wetzlar, Germany).

Protein extraction and western blotting
---------------------------------------

Podocytes were lysed in TSD lysis buffer (1% SDS, 50 mM pH 7.5 Tris-HCL, 50 mM DTT) containing protease inhibitors (Applygen Technologies Inc., Beijing, China). Total protein concentrations were measured using a bicinchoninic acid kit (Applygen Technologies Inc.). Following centrifugation at 12,000 × g for 10 min at 4°C, the lysate supernatants were prepared for western blotting. Human serum (obtained from one of the authors, female, 26 years old) enriched with Igs was used as a positive control. The cell supernatant was purified by affinity chromatography using protein G sepharose; the target protein was purified according to the manufacturer\'s protocol (R8300; Beijing SUOLAIBAO Biotechnology Co., Ltd.). The protein samples then underwent SDS-PAGE, western blot analysis and mass spectrometry, which was conducted by Beijing Protein Innovation (Beijing, China).

Western blotting was carried out according to standard procedures. Briefly, lysate proteins were separated by 10% SDS-PAGE and were transferred onto a nitrocellulose membrane. Subsequently, the membrane was blocked in 5% BSA (Amresco, LLC, Solon, OH, USA) and was incubated with primary antibodies at 4°C overnight, including rabbit anti-human Igγ (ab109489; 1:1,000), rabbit anti-human Igγ1 (ab108969; 1:1,000), rabbit anti-human Igγ2 (ab134050; 1:10,000), rabbit anti-human Igγ3 (ab109761; 1:5,000), rabbit anti-human Igγ4 (ab109493; 1:5,000) and anti-Igλ (ab124719; 1:20,000), rabbit anti-human β-actin (ab8227; 1:2,000), rabbit anti-human GAPDH (ab181602; 1:10,000) (all from Abcam), mouse anti-human Igκ (GTX21050; GeneTex, Inc., Irvine, CA, USA) and RP215 mAb. The membrane was then incubated with goat anti-rabbit (cat. no. 926-32211) or anti-mouse (cat. no. 926-32210) IgG-IRDyeTM680CW secondary antibodies (1:10,000; LI-COR Biosciences, Lincoln, NE, USA) at room temperature for 1 h. The results were analyzed using an Odyssey Infrared imager and Odyssey V3.0 software (LI-COR Biosciences).

Isolation of peripheral blood mononuclear cells (PBMCs)
-------------------------------------------------------

Mononuclear cells were prepared from the peripheral blood of a healthy person (author of the present study as mentioned above). PBMCs were isolated using Ficoll-Paque PLUS (GE Healthcare, Chicago, IL, USA) by density-gradient centrifugation. The cells from the interface of the solution were considered PBMCs, which were collected and washed in PBS. The isolated PBMCs were immediately utilized.

Reverse transcription-polymerase chain reaction (RT-PCR)
--------------------------------------------------------

Total RNA was extracted from podocytes and PBMCs according to a standard procedure using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.). RNA concentration was estimated using a NanoDrop spectrophotometer (NanoDrop Technologies; Thermo Fisher Scientific, Inc., Wilmington, DE, USA). Subsequently, RT was performed with oligo(dT) primer using GoScript™ Reverse Transcriptase (Promega Corporation, Madison, WI, USA) according to the manufacturer\'s protocol. Transcripts of the Igγ, Igκ, Igλ and Iγ-Cγ constant regions ([@b31-ijmm-41-06-3296]) were amplified by PCR using Taq PCR MasterMix (Beijing Biomed Biotechnology Co., Ltd., Beijing, China). Transcripts of the Igγ and Igκ variable regions were amplified by semi-nested PCR with Taq PCR MasterMix (Biomed). The PCR products were separated by electrophoresis on a 1.5% agarose gel at a constant voltage of 120 V for 40--50 min. The thermocycling conditions were as mentioned in previous studies ([@b6-ijmm-41-06-3296],[@b18-ijmm-41-06-3296]).

To detect the mRNA expression levels of recombination activating gene (RAG)1 and RAG2, a nested RT-PCR assay was used ([@b32-ijmm-41-06-3296]). Total RNA was treated with RQ1 RNase-free DNase (Promega Corporation) to eliminate the contamination of genomic DNA. The cDNA template was replaced with treated RNA as a negative control. For amplification of activation-induced cytidine deaminase (AID), the primer sequences and protocol were used as previously described ([@b33-ijmm-41-06-3296]). Details of the primer sequences used in the present study are listed in [Table I](#tI-ijmm-41-06-3296){ref-type="table"}. The reliability of PCR products was analyzed by DNA sequence analysis, which was performed by Invitrogen Trading (Shanghai) Co., Ltd. (Shanghai, China).

Analysis of rearrangement gene
------------------------------

PCR products of the Igγ and Igκ variable regions obtained from both PBMCs and podocytes were respectively cloned into a pGEM-T Easy Vector System I (A1360; Promega Corporation), which was transfected into Competent *Escherichia coli* TOP10 cells (Tiangen Biotech Co., Ltd., Beijing, China). The transfection experiments were performed according to the manufacturer\'s protocols. Briefly, ligation reactions were set up using transfection reagents in pGEM-T Easy Vector System I and the transformations were performed using the ligation reactions. Subsequently, clones were formed and amplified through the proliferation of bacteria. Following DNA sequencing with an ABI 3730XL Genetic Analyzer (Applied Biosystems; Thermo Fisher Scientific, Inc.), which was performed by Invitrogen Trading (Shanghai) Co., Ltd., the variable sequences were compared with germline gene segments using Basic Local Alignment Search Tool in the National Center for Biotechnology Information (NCBI) database (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>).

Small interfering (si)RNA transfection
--------------------------------------

Synthetic siRNA targeting the human Igγ chain constant region and control siRNAs were purchased from Shanghai GenePharma Co., Ltd. (Shanghai, China). The siRNA sequences were as follows, siRNA-1, 5′-GCA AGG AGU ACA AGU GCA ATT-3′, siRNA-2, 5′-CCG GAG AAC AAC UAC AAG ATT-3′, siRNA-3, 5′-CAC AAC CAC UAC ACA CAG ATT-3′, siRNA-positive control, 5′-UGA CCU CAA CUA CAU GGU U-3′, siRNA-negative control, 5′-UUC UCC GAA CGU GUC ACG UTT-3′. Lipofectamine 3000 transfection reagent (Invitrogen; Thermo Fisher Scientific, Inc.) was used to transfect the siRNAs into the podocyte cell line. Following transfection, which was conducted according to the manufacturer\'s protocol, the knockdown efficiency was detected by western blotting. Approximately 3×10^5^ cells/well were cultured in complete medium with a final siRNA concentration of 50 nM. The cells were transfected at 37°C for 48 h and subsequently collected for further experiments.

Cell viability assay
--------------------

Cell viability was measured by Cell Counting kit-8 (CCK-8; Dojindo Molecular Technologies, Inc., Kumamoto, Japan). Briefly, cells from each siRNA group were seeded into 3 wells of a 96-well plate for 48 h at 37°C (1,000--2,000 cells per well). Subsequently, the medium was replaced with 100 *µ*l fresh culture medium containing 8 *µ*l CCK-8 reagent. After incubation for 2 h at 37°C, a spectrophotometric microplate reader (BioTek Instruments, Inc., Winooski, VT, USA) was used to measure the absorbance at 450 nm; cell viability was indirectly reflected.

Cell adhesion assay
-------------------

To analyze the adhesive ability of the cells, a CCK-8 assay (Dojindo Molecular Technologies, Inc.) was conducted following siRNA transfection for 48 h. Briefly, 1×10^4^ cells resuspended in 100 *µ*l media were seeded in each well of a 96-well plate and were incubated at 37°C for 1 h. Each group (3 wells per group) including siRNA-1, siRNA-2, siRNA-3, siRNA-NC, mock and blank, was divided into 3 groups: washed, unwashed and blank group. In the washed group, the cells were washed gently with PBS three times and 100 *µ*l fresh media with 8 *µ*l CCK-8 reagent was added to the wells. In the unwashed group, the cells were added with 100 *µ*l fresh media with 8 *µ*l CCK-8 reagent. In the blank group, CCK-8 was directly added into the wells without cells. After incubation for 2 h at 37°C, the adhered cells were determined by detecting the absorbance at 450 nm using a spectrophotometric microplate reader (BioTek Instruments, Inc.). Cell adhesion was determined using the following formula: $$\text{Cell~adhesion~rate} = \frac{\text{OD}_{\text{washed}} - \text{OD}_{\text{blank}}}{\text{OD}_{\text{unwashed}} - \text{OD}_{\text{blank}}}$$

Statistical analysis
--------------------

Data are expressed as the means ± standard deviation and were analyzed by SPSS 20.0 software (IBM Corp., Armonk, NY, USA). All experiments were repeated 3 times. To determine significant differences between two groups, Student\'s t-test was used. The significant differences between more than two groups were analyzed using one-way analysis of variance and a least significant difference multiple comparison test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

IgG heavy and light chains were stained in human podocytes by immunofluorescence staining
-----------------------------------------------------------------------------------------

To determine the expression of IgG in podocytes, the present study conducted an immunofluorescence analysis using commercially available anti-human Igγ, Igγ1-4, Igκ and Igλ light chain antibodies; and RP215 mAb, which recognizes non-B cell-derived Igγ ([@b34-ijmm-41-06-3296]) ([Fig. 1](#f1-ijmm-41-06-3296){ref-type="fig"}). Positive staining of Igγ, γ4, κ and λ was detected in the cytoplasm of podocytes ([Fig. 1A, B, D and E](#f1-ijmm-41-06-3296){ref-type="fig"}). However, Igγ2 and Igγ3 staining was not found by immunofluorescence staining. Stronger positive staining of RP215 was predominantly localized in the cytoplasm and on the cell membrane of podocytes ([Fig. 1C](#f1-ijmm-41-06-3296){ref-type="fig"}).

Confirmation of the expression of IgG in podocytes by western blotting and mass spectrometry
--------------------------------------------------------------------------------------------

To confirm the expression of corresponding proteins, IgG heavy and light chains were detected in podocyte cell lysates and culture supernatants by western blotting. Human serum that contains a substantial amount of Igs was used as a positive control. In order to eliminate the interference of FBS in the media, FBS in electrophoresis was blotted with anti-human Igγ, κ and λ antibodies and negatively stained. The commercial anti-Igγ antibody and RP215 mAb detected Igγ at 55 kDa. In addition, subclasses of Igγ, including Igγ1 (52 kDa), Igγ3 (58 kDa), Igγ4 (36 kDa), were detected and the bands obtained were consistent with the predicted molecular weight, or the detected bands in the antibody instructions. However, Igγ2 expression was not found after several experiments. Furthermore, Igκ (25 kDa) and Igλ (50 kDa) expression was observed in the cell lysate ([Fig. 2A](#f2-ijmm-41-06-3296){ref-type="fig"}).

To further verify the secretion of IgG by podocytes, IgG was extracted from the culture supernatant using protein G beads, which bind to human IgG with high specificity. The protein in the eluate was recognized at 150 kDa and 55 kDa, following incubation with an anti-human IgG antibody. These weights correspond with the weight of the intact tetramer at 150 kDa and that of the single γ chain at 55 kDa ([Fig. 2B](#f2-ijmm-41-06-3296){ref-type="fig"}). Mass spectrometry demonstrated that the 150 kDa band contained segments of the Igγ1 chain constant region and Igλ chain VLJ region, according to the NCBI database ([Fig. 2C](#f2-ijmm-41-06-3296){ref-type="fig"}), and the Igγ1 chain constant region could be found at 55 kDa.

Transcription of IgG heavy and light chain constant regions and related enzymes in podocytes
--------------------------------------------------------------------------------------------

The expression levels of IgG genes and associated enzymes were explored in podocytes by RT-PCR. The B lymphocyte marker CD19 was used to exclude the possible contamination of B lymphocytes. CD19 expression was positive in the PBMC control group, but not in the podocyte group. The mRNA expression levels of Igγ, κ and λ constant regions, and the Igγ subclasses, including Igγ1, γ3 and γ4 constant regions were detected ([Fig. 3A](#f3-ijmm-41-06-3296){ref-type="fig"}), whereas Igγ2 was not; these results were similar to those of western blotting.

Notably, the mRNA expression levels of AID, which is the essential element for somatic hypermutation and class switch recombination (CSR) in B lymphocytes, and of RAG1 and RAG2, which are necessary for V(D)J rearrangement, were detected in human podocytes ([Fig. 3B](#f3-ijmm-41-06-3296){ref-type="fig"}), thus indicating that class switching of Igγ and gene rearrangement of the variable region may occur in podocytes.

After sequencing, the sequences of PCR products were aligned with the mRNA sequences available in the NCBI database; homologies between 96 and 99% were demonstrated ([Fig. 3C](#f3-ijmm-41-06-3296){ref-type="fig"}).

V(D)J rearrangement of the IgG variable region and rearrangement patterns
-------------------------------------------------------------------------

V(D)J rearrangements take place at the genomic level prior to the expression of corresponding proteins in B lymphocytes. By using semi-nested RT-PCR and DNA sequence analysis, the present study identified gene recombination sequences of IgG heavy and light chains in podocytes ([Fig. 3A](#f3-ijmm-41-06-3296){ref-type="fig"}). T-A cloning and sequencing demon strated that the Igγ and Igκ genes from clones had typical V(D)J rearrangements, with the V-D, D-J or V-J junctions (data not shown). All sequences obtained were productive and there were no stop codons in each region.

Notably, in contrast to the diverse gene rearrangements in B lymphocytes, the present study detected conservative V(D)J patterns in podocyte-derived Ig, with VH3-23/D3-22/JH4 (12/22), VH3-23/D3-16/JH4 (8/22) and VH3-23/D4-17/JH6 (2/22) as the predominant rearrangements in the γ chain variable region ([Table II](#tII-ijmm-41-06-3296){ref-type="table"}), and Vκ1-39/Jκ1 (10/10) in the κ chain variable region ([Table III](#tIII-ijmm-41-06-3296){ref-type="table"}).

SAC upregulates the expression of IgG and alters the conservative variable regions in podocytes
-----------------------------------------------------------------------------------------------

A total of 48 h after stimulation with SAC, Igγ, γ4 and λ were significantly upregulated (P\<0.05), and the mRNA expression levels of the Igγ and Ig κ variable regions were increased, thus indicating that SAC upregulated the expression of IgG in podocytes ([Fig. 4](#f4-ijmm-41-06-3296){ref-type="fig"}). Furthermore, the conservative rearrangements in the variable regions were altered following SAC incubation. In the SAC group, VH3-23/D1-7/JH6, VH3-23/D2-8/JH6 and VH3-30/ D3-16/JH6 rearrangements were found in the γ chain variable region ([Table II](#tII-ijmm-41-06-3296){ref-type="table"}). Vκ1-39/Jκ1 and Vκ1-12/Jκ4 rearrangements were found in the κ chain variable region ([Table III](#tIII-ijmm-41-06-3296){ref-type="table"})..

Downregulation of IgG following siRNA transfection, and its role in cell viability and adhesion
-----------------------------------------------------------------------------------------------

The present study used three siRNAs (siRNA 1-3) against the Igγ chain constant region. A total of 48 h post-transfection, western blot analysis was used to detect Igγ expression. The protein expression levels of Igγ were significantly reduced in podocytes by siRNA-1 ([Fig. 5A](#f5-ijmm-41-06-3296){ref-type="fig"}), thus indicating that siRNA-1 was effective.

To further confirm the involvement of podocyte-derived IgG in podocyte function, the alterations in cell morphology, viability and adhesion were detected in each group. Immunofluorescence assay using F-actin staining demonstrated that cell volume was reduced and morphology was altered in response to IgG expression knockdown in the siRNA-1 group ([Fig. 5B](#f5-ijmm-41-06-3296){ref-type="fig"}). Furthermore, in the siRNA-1 group, viability was reduced compared with in the other groups, including siRNA-NC, Mock and Blank (1.05±0.05 vs. 1.37±0.02, 1.32±0.04 and 1.47 ±0.03, respectively) (P\<0.01). In addition, adhesive capability was significantly reduced in the siRNA-1 group compared with in the other groups, including siRNA-NC, Mock and Blank (0.37±0.05 vs. 0.56±0.03, 0.52±0.03 and 0.65±0.05%) ([Fig. 5C and D](#f5-ijmm-41-06-3296){ref-type="fig"}) (P\<0.01), as determined by CCK-8 assay.

Discussion
==========

The present study detected the expression levels of IgG heavy and light chains at the protein and mRNA levels in podocytes. The results demonstrated that the expression was associated with cell viability and adhesion.

Firstly, the present study used immunofluorescence to determine the expression and distribution of Igγ, γ1-4 heavy chains, and κ and λ light chains in podocytes. Positive staining of Igγ, γ4, κ and λ chains was detected in the cytoplasm of podocytes, thus indicating that podocytes may express IgG. Shao *et al* ([@b35-ijmm-41-06-3296]) reported that IgM was expressed and presented in kidney tubules in *µ*MT mice, which have hardly any IgM in circulation due to the disruption of the *µ* heavy chain, thus lacking mature B cells. Compared with commercial antibodies, the RP215 antibody recognizes a specific carbohydrate-associated epitope on non-B cell-derived Igγ ([@b34-ijmm-41-06-3296]); in the present study, RP215 mAb detected IgG more clearly both on the cell membranes and in the cytoplasm, suggesting that podocyte-derived IgG was more likely to be non-B cell derived as the findings of Liao *et al* ([@b26-ijmm-41-06-3296]). The positive staining of Igγ4 is consistent with the fact that IgG4 is the predominant subtype of immune complexes in MN, which is the most common cause of adult nephrotic syndrome ([@b3-ijmm-41-06-3296]).

Western blotting confirmed that the Igγ protein band was recognized by a commercial anti-Igγ antibody at 55 kDa, thus indicating that podocyte-derived Ig may have a similar molecular size to that in circulation. Similar to the immunofluorescence findings, RP215 mAb binding suggested that podocyte-derived IgG was more similar to non-B cell-derived IgG and contained a unique glycosylated epitope ([@b25-ijmm-41-06-3296]). In addition, the present study detected subclasses of Igγ, with Igγ1 and γ3 located at 52 and 58 kDa, respectively, which were near the molecular weight of Igγ in the serum. Igγ4 was located at 36 kDa, which was consistent with the predicted molecular weight in the antibody instructions. Furthermore, Igκ in the podocyte lysate had the same weight as in the serum at 25 kDa, whereas Igλ was detected at 50 kDa, just two times the weight of a single λ chain, which may be attributable to modification or polymerization. To determine if podocytes secreted IgG, protein G sepharose and affinity chromatography were conducted; IgG with a molecular weight of 150 kDa, as an intact tetramer, and 55 kDa, as a single heavy chain, were obtained in the supernatant. Mass spectrometry indicated that the 150 kDa band contained segments of Igγ1 constant region and λ chain, whereas the 55 kDa band contained peptides from the Igγ1 chain constant region, further suggesting that podocytes may synthesize and secrete full length IgG.

Ig gene recombination and transcription are prerequisites for protein production. In the present study, we first eliminated B lymphocyte contamination by detecting the CD19 expression and then obtained the positive amplification of the mRNA of Igγ, γ1, γ3, γ4 subclasses, κ and λ constant regions. After DNA sequencing, the PCR products conformed to the Ig mRNA sequences contained in the NCBI database, indicating that transcription of the IgG gene occurs in podocytes. During the process of B lymphocyte development, the variable region of the IgG heavy and light chains undergoes rearrangement, thus generating antibody diversity ([@b36-ijmm-41-06-3296]). Furthermore, podocytes have the ability to amplify functional transcripts of Igγ and κ light chain variable regions. The present study compared the podocyte-derived V(D)J rearrangements of Ig transcripts with conventional V(D)J rearrangements in B cells. Although they displayed some common characteristics, including different junctions between V-D, D-J or V-J segments, numerous gene rearrangement differences existed between podocytes and B lymphocytes. Firstly, podocyte-derived Igγ and κ chains exhibited restricted rearrangement patterns compared with B cells, which exhibit Ig diversity; this result is in accordance with the findings of other studies ([@b12-ijmm-41-06-3296],[@b18-ijmm-41-06-3296]). Secondly, more common V segments were detected in podocyte as the VH3 gene family was present in all clones with VH3-23 positive in 34 clones (75.6%) and VH3-30 in 11 clones (24.4%), which was similar to the reports of Glanville *et al* ([@b37-ijmm-41-06-3296]). Finally, some stimulating factors, including SAC may alter the selection trends of rearrangement patterns in podocytes.

Gene rearrangement is initiated by RAG1 and RAG2 specifically binding to the recombination signal sequence. Subsequently, this compound cleaves DNA and induces the recombination of V, D and J segments ([@b38-ijmm-41-06-3296]). The present study detected RAG1 and RAG2 mRNA expression in human podocytes by nested RT-PCR, as in other studies ([@b6-ijmm-41-06-3296],[@b9-ijmm-41-06-3296]). When the body is stimulated by antigens, somatic hypermutation and CSR induce the generation of additional gene alterations. The present study demonstrated that transcription of AID, which is an important mediator of CSR and somatic hypermutation, exists in podocytes. These results indicated that V(D)J rearrangement and CSR may take place in podocytes, with a similar mechanism to in B lymphocytes.

Previous studies have suggested that non-B cell-derived Igs are associated with cell growth and proliferation ([@b6-ijmm-41-06-3296],[@b23-ijmm-41-06-3296],[@b24-ijmm-41-06-3296]). In the kidney, cytoskeletal dynamics determine the correct morphology of podocytes, and the slit diaphragm complex, actin cytoskeleton and cell adhesion molecules form an intricate network to stabilize filtration barrier function ([@b39-ijmm-41-06-3296],[@b40-ijmm-41-06-3296]). Conversely, foot process fusion is a pathobiological manifestation of glomerular diseases, including MN. To investigate the association between IgG expression and cellular functions, siRNA targeting the Igγ constant region was transfected into podocytes. In response to IgG knockdown, cell viability and adhesion were reduced, and alterations were detected in the actin cytoskeleton, thus indicating that IgG expression was associated with cellular bioactivities, including survival, proliferation and adhesion ([@b6-ijmm-41-06-3296]).

In conclusion, the present study demonstrated that human podocytes exhibit the capacity to produce IgG, and IgG expression is significantly upregulated when podocytes are stimulated by SAC. In addition, downregulation of IgG may have negative consequences for cell survival, viability and adhesion. The present study is the first, to the best of our knowledge, to indicate that IgG may be expressed in podocytes and provides additional evidence to suggest that Igs may be produced in cells other than B lymphocytes. The potential role of podocyte-derived IgG in the pathogenesis of podocytic diseases, such as membranous nephropathy (MN), focal segmental glomerular sclerosis (FSGS), and its possible clinical application, require further investigation.
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![IgG was detected in human podocytes by immunofluorescence staining. (A) Anti-Igγ, (B) anti-Igγ4, (C) RP215, (D) anti-Igκ and (E) anti-Igλ staining; (F) PBS was used as a negative control. Igs were immunostained (green) and nuclei were stained with DAPI (blue). Scale bar, 50 *µ*m. IgG, immunoglobulin G; Igγ, IgG heavy chain.](IJMM-41-06-3296-g00){#f1-ijmm-41-06-3296}

![Expression of IgG in cell lysate and supernatant of podocytes. (A) Igγ expression in the cell lysate was detected using a commercial anti-Igγ antibody and RP215 monoclonal antibody with western blotting. Igκ, Igλ, subclasses of Igγ, with the exception of Igγ2, were also detected using commercial antibodies. Serum from a healthy subject was used as a positive control. (B) Igγ was purified from the cell supernatant by affinity chromatography using protein G sepharose; serum from a healthy subject was used as a positive control. (C) Mass spectrometry results. Bold sequences refer to the alignment of an amino acid sequence with Igγ1 chain constant region protein and Igλ chain VLJ region in the National Center for Biotechnology Information database. HPC, human podocytes; IgG, immunoglobulin G; Igγ, IgG heavy chain.](IJMM-41-06-3296-g01){#f2-ijmm-41-06-3296}

![Detection of the mRNA expression levels of IgG and related enzymes, including RAG1, RAG2 and AID in podocytes. (A) Transcripts of Igγ, γ1, γ3, γ4, κ and λ C regions were detected by RT-PCR. CD19 was detected as a marker of B lymphocytes. The mRNA of Igγ and κ V regions was amplified by nested RT-PCR. (B) mRNA expression levels of AID, RAG1 and RAG2. PBMCs were used as a positive control; water instead of cDNA was used as a blank control; R (cDNA template replaced by DNase-treated RNA) was used as negative control. (C) DNA sequencing results. The sequences of the PCR products were aligned with the mRNA sequences available in the NCBI database. HPC, human podocytes; AID, activation-induced cytidine deaminase; C, constant; Ig, immunoglobulin; Igγ, IgG heavy chain; PBMCs, peripheral blood mononuclear cells; RAG. recombination activating gene; RT-PCR, reverse transcription-polymerase chain reaction; V, variable.](IJMM-41-06-3296-g02){#f3-ijmm-41-06-3296}

![IgG expression in the podocyte cell lysate was increased following SAC treatment for 48 h. (A) Western blot analysis of the protein expression levels of Igγ, γ4, κ and λ. (B) mRNA expression levels of the Igγ and Igκ V regions were evaluated by reverse transcription-polymerase chain reaction. (C) Expression levels of Igγ, γ4 and λ were evaluated and semi-quantified according to the expression of the internal control. β-actin was used as an internal control. Data are presented as the means ± standard deviation, n=3. ^\*^P\<0.05. Ig, immunoglobulin; Igγ, IgG heavy chain; PBMC, peripheral blood mononuclear cells; SAC, *Staphylococcus aureus*; V, variable.](IJMM-41-06-3296-g03){#f4-ijmm-41-06-3296}

![IgG expression 48 h post-transfection with siRNA. (A) Western blot analysis confirmed successful knockdown of IgG in podocytes by siRNAs. GAPDH was used as a positive control. (B) Immunofluorescence assay of F-actin and Igγ staining. F-actin and IgG were immunostained (green), and nuclei were stained with DAPI (blue).(C) CCK-8 analysis of cell viability. (D) CCK-8 analysis of the adhesive ability of podocytes. siRNA-1, siRNA-2 and siRNA-3, siRNAs targeted the Igγ constant region; siRNA-PC, siRNA targeted GAPDH; siRNA-NC, scrambled siRNA; mock, cells treated with only Lipofectamine 3000; blank, untreated cells; FBS, culture medium without cells. Scale bar, 50 *µ*m. Data are presented as the means ± standard deviation, n=3. \*\*P\<0.01. CCK-8, Cell Counting kit-8; FBS, fetal bovine serum; Ig, immunoglobulin; Igγ, IgG heavy chain; NC, negative control; OD, optical density; PC, positive control.](IJMM-41-06-3296-g04){#f5-ijmm-41-06-3296}

###### 

Sequences of polymerase chain reaction primers used in the present study.

  Gene name            Primer                         Primer sequence (5′-3′)        Product length (bp)
  -------------------- ------------------------------ ------------------------------ ---------------------
  Ig Vγ                External sense                 VH1:GAGGTGCAGCTCGAGGAGTCTGGG   
                       VH2:CAGGTGCAGCTCGAGCAGTCTGGG                                  
                       VH3:CAGGTACAGCTCGAGCAGTCAGG                                   
                       VH4:CAGGTGCAGCTGCTCGAGTCGGG    280--300                       
  External antisense   CH1:ACACCGTCACCGGTTCGG                                        
  Internal antisense   FR2:TGGRTCCGVCAGSCYCCNGG                                      
  Internal antisense   JH:AACTGCAGAGGAGACGGTGACC                                     
  Ig Vκ                External sense                 GACATCGAGCTCACCCAGTCTCC        340--360
  External antisense   CGGGAAGATGAAGACAGATGGTGC                                      
  Internal sense       GAAATTGAGCTCACGCAGTCTCCA                                      
  Internal antisense   TGGTGCAGCCACAGTTCGTT                                          
  Ig Cγ                Sense                          AGGACTCTACTCCCTCAGCAG          566
  Antisense            TCAGGCTGACCTGGTTCTTG                                          
  Ig Cκ                Sense                          TGAGCAAAGCAGACTACGAGA          231
  Antisense            GGGGTGAGGTGAAAGATGAG                                          
  Ig Cλ                Sense                          GGGACCAAGCTCACCGTCCTAG         316
  Antisense            TCTTCTCCACGGTGCTCCCTTC                                        
  Ig Cγ1               Sense                          GGGCTTCCAAGCCAACAGGGCAGGACA    603
  Antisense            GTTTTGTCACAAGATTTGGGCTC                                       
  Ig Cγ2               Sense                          GGGCTTCCAAGCCAACAGGGCAGGACA    597
  Antisense            GTGGGCACTCGACACAACATTTGCG                                     
  Ig Cγ3               Sense                          AGGTGGGCAGGCTTCAGGCACCGAT      670
  Antisense            TTGTGTCACCAAGTGGGGTTTTGAGC                                    
  Ig Cγ4               Sense                          GATGGCGTGGAGGTGCATAA           212
  Antisense            GTGTACACCTGTGGCTCTCG                                          
  AID                  Sense                          GAGGCAAGAAGACACTCTG            647
  Antisense            GTGACATTCCTGGAAGTTGC                                          
  RAG1                 External sense                 TGGATCTTTACCTGAAGATG           327
  External antisense   CTTGGCTTTCCAGAGAGTCC                                          
  Internal sense       CACAGCGTTTTGCTGAGCTC                                          
  Internal antisense   AGCTTGCCTCAGGGTTCATG                                          
  RAG2                 External sense                 TGGAAGCAACATGGGAAATG           193
  External antisense   CATCATCTTCATTATAGGTGTC                                        
  Internal sense       TTCTTGGCATACCAGGAGAC                                          
  Internal antisense   CTATTTGCTTCTGCACTG                                            
  CD19                 Sense                          AAGGGGCCTAAGTCATTGCT           347
  Antisense            CACGTTCCCGTACTGGTTCT                                          
  β-actin              Sense                          AGAGCTATGAGCTGCCTGAC           121
  Antisense            AATTGAATGTAGTTTCATGGATG                                       

AID, activation-induced cytidine deaminase; C, constant; CD19, cluster of differentiation 19; Ig, immunoglobulin; RAG, recombination activating gene; V, variable.

###### 

IGHV/IGHD/IGHJ rearrangement patterns of the Ig heavy chain variable region in podocytes and PBMCs.

  Name of cells     No. of clones                                  IGHV/IGHD/IGHJ usage                        Identity with germlines (%)
  ----------------- ---------------------------------------------- ------------------------------------------- -----------------------------
  Podocytes (NC)    12                                             IGHV3-23^\*^01/IGHD3-22^\*^01/IGHJ4^\*^02   88.8--90.6
  8                 IGHV3-23^\*^01/IGHD3-16^\*^02/IGHJ4^\*^02      85.9--87.0                                  
  2                 IGHV3-23^\*^01/IGHD4-17^\*^01/IGHJ6^\*^03      89.0--91.6                                  
  Podocytes (SAC)   6                                              IGHV3-23^\*^01/IGHD1-7^\*^01/IGHJ6^\*^03    91.6--94.8
  6                 IGHV3-23^\*^01/IGHD2-8^\*^01/IGHJ6^\*^02       84.6--86.3                                  
  10                IGHV3-30-3^\*^03/IGHD3-16^\*^02/ IGHJ6^\*^02   88.0--90.1                                  
  1                 IGHV3-30-3^\*^01/IGHD2-15^\*^01/ IGHJ4^\*^02   96.9                                        
  PBMCs (control)   1                                              IGHV5-51^\*^01/IGHD3-22^\*^01/IGHJ3^\*^02   96.9
  1                 IGHV3-7^\*^03/IGHD1-26^\*^01/IGHJ4^\*^02       92.3                                        
  1                 IGHV3-11^\*^05/IGHD1-26^\*^01/IGHJ4^\*^02      95.4                                        
  1                 IGHV6-1^\*^02/IGHD5-24^\*^01/IGHJ4^\*^02       93.9                                        
  1                 IGHV3-33^\*^03/IGHD5-24^\*^01/IGHJ6^\*^03      96.9                                        
  1                 IGHV3-7^\*^01/IGHD3-16^\*^02/IGHJ4^\*^02       91.7                                        

Ig, immunoglobulin; NC, negative control; PBMCs, peripheral blood mononuclear cells; SAC, *Staphylococcus aureus*.

###### 

IGKV/IGKJ rearrangement patterns of the Igκ variable region in podocytes and PBMCs.

  Name of cells     No. of clones                IGKV/IGKJ usage              Identity with germlines (%)
  ----------------- ---------------------------- ---------------------------- -----------------------------
  Podocytes (NC)    10                           IGKV1-39^\*^01/IGKJ1^\*^01   92.9--93.6
  Podocytes (SAC)   3                            IGKV1-39^\*^01/IGKJ1^\*^01   90.1--90.5
  8                 IGKV1-12^\*^01/IGKJ4^\*^01   90.1--95.3                   
  PBMC (control)    1                            IGKV1-9^\*^01/IGKJ1^\*^01    91.5
  1                 IGKV1-12^\*^01/IGKJ4^\*^02   83.5                         
                    1                            IGKV1-39^\*^01/IGKJ2^\*^02   95.3
                    1                            IGKV1-39^\*^01/IGKJ5^\*^01   88.0
                    1                            IGKV2-29^\*^02/IGKJ2^\*^01   94.7
                    2                            IGKV4-1^\*^01/IGKJ2^\*^01    98.0
                    2                            IGKV4-1^\*^01/IGKJ3^\*^01    96.4
                    1                            IGKV4-1^\*^01/IGKJ4^\*^01    92.7

Ig, immunoglobulin; NC, negative control; PBMCs, peripheral blood mononuclear cells; SAC, *Staphylococcus aureus*.
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